Roquette Acquires Indian Excipient Manufacturer

Roquette, a French-based provider of pharmaceutical and nutraceutical excipients, has acquired Crest Cellulose, an Indian excipient manufacturer, reinforcing its presence in India and Asia.

© Roquette
© Roquette

The move follows Roquette’s purchase of a majority stake in Crest Cellulose from Indian pharma packaging company Pravesha Industries in December 2018. A privately owned company based in Mumbai, Crest Cellulose has locations in Hyderabad and Nellore, manufacturing a wide range of “superior” excipients.

“The team at Crest Cellulose share our conviction that quality is king, always striving to optimize processes and redefine what’s possible in drug delivery. As a global leader in health and nutrition, we’re excited to harness our newly expanded capabilities to support our network of customers and partners in India, Asia and the rest of the world,” said Paul Smaltz, vice president at Roquette Pharma Solutions.

According to Roquette, India’s pharma industry is poised for a period of seismic growth and production of generics in the Asia-Pacific region is also expanding.  

Author: Elaine Burridge, Freelance Journalist

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.